Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone metastasis].

O S Nielsen, H Skovgaard Poulsen

    Ugeskrift for Laeger
    |February 6, 1989
    PubMed
    Summary

    Bone metastases, common in breast, prostate, and lung cancers, require palliative treatment for pain and fracture prevention. Further research is needed to evaluate various treatment efficacies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Influence of volumetric modulated arc therapy and FET-PET scanning on treatment outcomes for glioblastoma patients.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2018
    Same author

    Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Functional outcome in sarcomas treated with limb-salvage surgery or amputation.

    Sarcoma·2008
    Same author

    Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group.

    Sarcoma·2008
    Same author

    Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group.

    European journal of cancer (Oxford, England : 1990)·2007
    Same author

    Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas.

    European journal of cancer (Oxford, England : 1990)·2006

    Area of Science:

    • Oncology
    • Skeletal Metastasis Research

    Context:

    • Bone metastases are a frequent early sign of advanced cancer, primarily from breast, prostate, and lung primaries.
    • While prognosis is serious, many patients survive for years, necessitating active management.
    • Over 25% of patients are asymptomatic, while pain is the dominant symptom for others.

    Purpose:

    • To outline the palliative treatment strategies for bone metastases.
    • To highlight common complications such as pathological fractures, hypercalcemia, and spinal cord compression.
    • To emphasize the need for more rigorous clinical investigations into treatment efficacy.

    Summary:

    • Diagnosis involves clinical assessment, lab tests, skeletal X-rays, and bone scintigraphy.
    • Treatment focuses on pain relief, fracture prevention, and maintaining function, utilizing local (surgery, irradiation) and systemic (chemotherapy, endocrine therapy, diphosphonates) approaches.
    • Irradiation remains a primary treatment modality, with significant pain relief reported in about 80% of patients.

    Impact:

    • Current treatment offers palliative benefits, with 50-70% of survivors pain-free at 12 months post-treatment.
    • Limited randomized trials and interpretative challenges in response criteria underscore the need for more controlled studies.
    • Improved understanding and validation of therapeutic options are crucial for optimizing patient care and outcomes in bone metastasis management.

    Related Experiment Videos